富士製薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/07/21 | 1,133 | 1,143 | 1,128 | 1,140 | +7 | +0.6% | 32,700 |
| 2023/07/20 | 1,140 | 1,140 | 1,127 | 1,133 | -2 | -0.2% | 33,500 |
| 2023/07/19 | 1,122 | 1,136 | 1,120 | 1,135 | +23 | +2.1% | 49,300 |
| 2023/07/18 | 1,110 | 1,120 | 1,110 | 1,112 | +2 | +0.2% | 43,400 |
| 2023/07/14 | 1,113 | 1,117 | 1,106 | 1,110 | -4 | -0.4% | 29,700 |
| 2023/07/13 | 1,108 | 1,118 | 1,101 | 1,114 | +4 | +0.4% | 47,000 |
| 2023/07/12 | 1,121 | 1,121 | 1,109 | 1,110 | -12 | -1.1% | 54,800 |
| 2023/07/11 | 1,127 | 1,130 | 1,116 | 1,122 | -3 | -0.3% | 62,900 |
| 2023/07/10 | 1,125 | 1,132 | 1,123 | 1,125 | -4 | -0.4% | 57,600 |
| 2023/07/07 | 1,130 | 1,138 | 1,120 | 1,129 | -4 | -0.4% | 50,100 |
| 2023/07/06 | 1,140 | 1,140 | 1,131 | 1,133 | -8 | -0.7% | 56,600 |
| 2023/07/05 | 1,133 | 1,141 | 1,125 | 1,141 | -1 | -0.1% | 63,600 |
| 2023/07/04 | 1,155 | 1,155 | 1,141 | 1,142 | -21 | -1.8% | 63,200 |
| 2023/07/03 | 1,174 | 1,178 | 1,163 | 1,163 | ±0 | ±0% | 31,700 |
| 2023/06/30 | 1,169 | 1,169 | 1,160 | 1,163 | -11 | -0.9% | 39,000 |
| 2023/06/29 | 1,175 | 1,182 | 1,168 | 1,174 | +1 | +0.1% | 57,200 |
| 2023/06/28 | 1,156 | 1,173 | 1,152 | 1,173 | +15 | +1.3% | 88,000 |
| 2023/06/27 | 1,181 | 1,184 | 1,156 | 1,158 | +5 | +0.4% | 91,800 |
| 2023/06/26 | 1,151 | 1,163 | 1,133 | 1,153 | +3 | +0.3% | 49,900 |
| 2023/06/23 | 1,167 | 1,177 | 1,149 | 1,150 | -11 | -0.9% | 61,600 |
| 2023/06/22 | 1,157 | 1,163 | 1,151 | 1,161 | +10 | +0.9% | 46,100 |
| 2023/06/21 | 1,140 | 1,155 | 1,139 | 1,151 | +11 | +1% | 73,000 |
| 2023/06/20 | 1,125 | 1,140 | 1,122 | 1,140 | +17 | +1.5% | 75,400 |
| 2023/06/19 | 1,114 | 1,123 | 1,111 | 1,123 | +16 | +1.4% | 68,700 |
| 2023/06/16 | 1,117 | 1,118 | 1,107 | 1,107 | -6 | -0.5% | 115,700 |
| 2023/06/15 | 1,125 | 1,129 | 1,113 | 1,113 | -16 | -1.4% | 47,400 |
| 2023/06/14 | 1,133 | 1,133 | 1,121 | 1,129 | -2 | -0.2% | 46,700 |
| 2023/06/13 | 1,129 | 1,137 | 1,125 | 1,131 | +3 | +0.3% | 49,800 |
| 2023/06/12 | 1,136 | 1,140 | 1,127 | 1,128 | -6 | -0.5% | 37,800 |
| 2023/06/09 | 1,127 | 1,137 | 1,116 | 1,134 | +20 | +1.8% | 64,300 |
| 2023/06/08 | 1,119 | 1,124 | 1,107 | 1,114 | -5 | -0.4% | 69,700 |
| 2023/06/07 | 1,141 | 1,146 | 1,119 | 1,119 | -25 | -2.2% | 81,200 |
| 2023/06/06 | 1,152 | 1,152 | 1,135 | 1,144 | -1 | -0.1% | 59,700 |
| 2023/06/05 | 1,156 | 1,165 | 1,145 | 1,145 | -6 | -0.5% | 44,300 |
| 2023/06/02 | 1,145 | 1,154 | 1,140 | 1,151 | +7 | +0.6% | 33,200 |
| 2023/06/01 | 1,144 | 1,157 | 1,140 | 1,144 | +7 | +0.6% | 34,900 |
| 2023/05/31 | 1,170 | 1,170 | 1,135 | 1,137 | -45 | -3.8% | 80,900 |
| 2023/05/30 | 1,190 | 1,199 | 1,173 | 1,182 | -7 | -0.6% | 27,500 |
| 2023/05/29 | 1,184 | 1,193 | 1,178 | 1,189 | +8 | +0.7% | 36,800 |
| 2023/05/26 | 1,210 | 1,210 | 1,179 | 1,181 | -29 | -2.4% | 34,400 |
| 2023/05/25 | 1,209 | 1,216 | 1,203 | 1,210 | +4 | +0.3% | 26,500 |
| 2023/05/24 | 1,207 | 1,223 | 1,205 | 1,206 | -1 | -0.1% | 24,100 |
| 2023/05/23 | 1,205 | 1,231 | 1,202 | 1,207 | +2 | +0.2% | 72,200 |
| 2023/05/22 | 1,188 | 1,209 | 1,188 | 1,205 | +17 | +1.4% | 39,400 |
| 2023/05/19 | 1,164 | 1,189 | 1,156 | 1,188 | +30 | +2.6% | 96,900 |
| 2023/05/18 | 1,163 | 1,163 | 1,151 | 1,158 | +4 | +0.3% | 66,400 |
| 2023/05/17 | 1,162 | 1,170 | 1,154 | 1,154 | -8 | -0.7% | 73,400 |
| 2023/05/16 | 1,165 | 1,174 | 1,146 | 1,162 | -1 | -0.1% | 98,200 |
| 2023/05/15 | 1,185 | 1,187 | 1,153 | 1,163 | -22 | -1.9% | 104,100 |
| 2023/05/12 | 1,186 | 1,194 | 1,147 | 1,185 | -61 | -4.9% | 241,800 |
201～
250
件表示中 / 6710件
類似銘柄と比較する
現在ご覧いただいている「富士製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 富士製薬 | 152,400円 | +12.7% | +1.8% | 2.79% | 5.99倍 | 0.84倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| あすかＨＤ | 230,900円 | +0.3% | +2.7% | 2.17% | 13.08倍 | 1.05倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| 生化学 | 78,200円 | +10.5% | +169.1% | 3.84% | 12.37倍 | 0.59倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
| ダイト | 230,300円 | +5.3% | -7.1% | 2.61% | 10.67倍 | 0.68倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
| ミズホメディ | 345,500円 | -5.1% | -21.2% | 4.63% | 10.91倍 | 2.10倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
市場注目の銘柄
チャート関連のコラム
